Transforming Health Through Early Detection and Regenerative Medicine

Prangenix develops multi-disease omics diagnostics and next-generation therapeutics targeting quiescent stem cells — starting with head and neck cancer.

Multi-Omics Diagnostics & Regenerative Therapeutics

Prangenix Therapeutics Pvt. Ltd. is a platform-first biotech developing affordable liquid biopsy diagnostics and regenerative therapies targeting quiescent stem cells (qSCs). Our immediate focus is early detection of head and neck cancers (HNSCC), while our long-term vision is a scalable, multi-disease platform leveraging single-cell sequencing, CRISPR, and AI to deliver accessible and precise care across cancer and chronic diseases.

Two-Track Diagnostic Models

Track 1: Diagnostics (Dx) — Detect. Monitor.

Detect mutations, gene fusions, and epigenetic changes through circulating free DNA (cfDNA) and cfRNA, enabling early-stage detection and monitoring of treatment response without invasive biopsies.

Track 2: Therapeutics (Rx) — Target

Capture quiescent stem cells (qSCs) from blood or tissue, apply single-cell sequencing, and create therapeutic blueprints for regenerative medicine and targeted therapies.

Next-Gen Cancer Diagnostics and Therapeutic Blueprinting

At Prangenix Therapeutics, we are building a next-gen platform for modular diagnostics, rare-cell profiling, and therapeutic blueprinting—designed to bring clarity, control, and customization to cancer and chronic disease care. Our goal is simple: make high-resolution molecular insight not only possible, but practical— for researchers, clinicians, and biotech innovators.

Modular Liquid & Tissue Diagnostics

Advanced liquid and tissue-based diagnostic platforms designed to detect early disease biomarkers with high accuracy and reliability.

Rare-Cell & qSC Profiling

Profiling of rare cells and quiescent stem cells (qSc) to understand resistance pathways and enable targeted therapeutic strategies.

Therapeutic Blueprinting

Personalized therapeutic blueprinting through CRISPR designs, CAR constructs, and precision solutions to transform cancer treatment outcomes.

Frequently Asked Questions

1. What is precision oncology?

Precision oncology is a modern approach to cancer care that uses advanced tools like molecular testing and genomic profiling to understand a patient’s cancer at a deeper level. At Prangenix, we use precision oncology to offer tailored diagnostics and treatment guidance for better outcomes.

2. What is a liquid biopsy, and how does it work?

A liquid biopsy is a simple, non-invasive blood test that detects cancer-related markers like cfDNA and cfRNA. It allows early detection and monitoring of cancer without the need for surgical procedures. Prangenix specializes in ultra-sensitive liquid biopsy panels for accurate diagnosis and follow-up.

3. How does Prangenix help in early cancer detection?

We use advanced molecular diagnostics, including cfDNA, cfRNA, and biomarker analysis, to detect early signals of cancer—even before symptoms appear. This allows for faster diagnosis and proactive treatment planning.

4. Is Prangenix only for hospitals and doctors?

No. Our services are open to everyone—patients, doctors, hospitals, and research institutes. We work with oncologists, ENT specialists, public health programs, and individuals seeking early and accurate cancer diagnostics.

5. What is Regenerative Medicine?

Regenerative medicine is a field focused on repairing, replacing, or regenerating damaged tissues and organs using advanced techniques like stem cell therapy, tissue engineering, and gene editing. It aims to restore normal function, treat chronic diseases, and address organ shortages, revolutionizing healthcare with innovative, patient-specific solutions.

6. What are Quiescent stem cells (qSCs)?

Quiescent stem cells (qSCs) are dormant, non-dividing stem cells that reside in specific niches, maintaining tissue homeostasis. They activate to repair damage or replenish cells, ensuring long-term tissue regeneration. Their significance lies in their role in preventing stem cell exhaustion and supporting therapeutic applications in regenerative medicine.

7. Can your tests be used to monitor treatment progress?

Yes. Our diagnostics are designed not just for detection but also for tracking how well a treatment is working and checking for early signs of relapse. This helps in adjusting therapies as needed.

8. How can I get tested or collaborate with Prangenix?

You can contact us through our website or by visiting our diagnostics center. We also welcome partnerships with hospitals, doctors, research labs, and biotech companies interested in advancing cancer diagnostics and personalized therapeutics.